Vitiligo, a common depigmenting skin disorder, has an estimated prevalence of 0.5–2% of
the population worldwide. The disease is characterized by the selective loss of melanocytes …

Vitiligo is a multifactorial reversible skin disorder characterized by distinct white patches that
result from melanocyte destruction. Activated CXCR3+ CD8+ T cells promote melanocyte …

Background Vitiligo is a chronic autoimmune disease that causes skin depigmentation. A
cream formulation of ruxolitinib (an inhibitor of Janus kinase 1 and 2) resulted in …

Vitiligo is the most common depigmenting disorder affecting 0.1%–2% of the population
worldwide. The characteristic white patches result from the selective loss of melanocytes …

Vitiligo is a complex disease whose pathogenesis results from the interaction of genetic
components, metabolic factors linked to cellular oxidative stress, melanocyte adhesion to the …

Background Vitiligo, an autoimmune disorder characterised by skin depigmentation, is
associated with reduced quality of life (QoL). Vitiligo may be under‐reported, in part because …

Mitochondrial dysregulation has been implicated in oxidative stress-induced melanocyte
destruction in vitiligo. However, the molecular mechanism underlying this process is merely …

Ultraviolet radiation (UVR) has numerous effects on skin, including DNA damage, tanning,
vitamin D synthesis, carcinogenesis, and immunomodulation. Keratinocytes containing …

The Koebner phenomenon, also known as isomorphic reaction, refers to the development of
secondary lesions with the same clinical manifestations and histopathological …

Vitiligo is a multifactorial disease characterized by the loss of skin pigment, which results in
achromic macules and patches. There are currently several medical treatments available …